Back

International Registry of Anakinra for Pericarditis

31 August 2019 (11:00 - 11:17)
Organised by:
Congress Presentation Part of: Late Breaking Science in Cardiovascular Pharmacology Treatment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Massimo Imazio

University Hospital Santa Maria della Misericordia, Udine (Italy)

4 More presentations in this session

Presentation thumbnail
A risk based approach to the role of aspirin on cardiovascular risk reduction in a healthy older cohort
Professor C. Reid (Melbourne, AU)
Slides Video
Presentation thumbnail
Relationship between hypoglycaemia, outcomes and empagliflozin treatment effect in EMPA-REG OUTCOME
Doctor D. Fitchett (Toronto, CA)
Slides Video
Presentation thumbnail
Effects of omega-3 fatty acid supplements on arrhythmias in the ASCEND study
Professor S. Parish (Oxford, GB)
Slides Video
Presentation thumbnail
Combination of low dose rivaroxaban and aspirin in females and males with chronic coronary artery disease or peripheral artery disease
Doctor Y. Liang (Beijing, CN)
Slides Video

Access the full session

Session thumbnail
Late Breaking Science in Cardiovascular Pharmacology

The Event

Event poster

ESC Congress 2019

31 August 2019 11:00 CET
You may be interested in
thumbnail
Congress Presentation
A case of recurrent pericarditis associated with abrupt withdrawal of Anakinra.
28 August 2022
thumbnail
Congress Presentation
Interleukin-1 blockade with Anakinra in ST-segment elevation acute myocardial infarction: Results from the VCUART3 study
3 September 2019
thumbnail
Congress Presentation
Genetic analysis of NLRP3 in recurrent pericarditis
27 August 2021
thumbnail
Webinar
Myocarditis and pericarditis: what every cardiologist must know about therapy
26 November 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources